Navigation Links
Relieving Pain for Diabetes Patients with Neuropathy
Date:12/10/2013

WALTHAM, Mass., Dec. 10, 2013 /PRNewswire/ -- Is there anything more frustrating than waking up in the middle of a nice dream? Awakening in the middle of the night can negatively affect one's mood the next day. It's one thing to be roused by an alarm clock or persistent pet that wants to be fed or walked, but being jolted out of sleep by agonizing leg pain is another story. Unfortunately, many of those who suffer from a condition called Painful Diabetic Neuropathy (PDN) are all too familiar with this occurrence.  

PDN affects many people with diabetes. They might experience burning, stabbing or shooting pains in the feet or legs, especially when trying to sleep. The pain is often so severe it either makes falling sleep impossible or wakes them up.

Luckily, a company called NeuroMetrix, Inc. has recognized the need for a treatment that will work while the patient sleeps. NeuroMetrix is a Waltham, MA-based medical device company that develops and markets tests and therapies for diabetic neuropathies. They have developed the SENSUS™ Pain Management System, an innovative new device to provide relief to those suffering from chronic diabetes pain. As Shai Gozani, President and CEO of NeuroMetrix, reports, "People often describe the pain to be like walking on a bed of nails or feeling like their feet are on fire. SENSUS may help relieve that pain."

One of the best parts about SENSUS is that it's lightweight and discreet. Wrapping around the patient's calf, it can be worn right under clothing. Its easy one-button control makes it the ideal solution for PDN sufferers of any age. It is non-addictive, non-narcotic, free of side effects and provides pain relief even during sleep. SENSUS is also the first transcutaneous electrical nerve stimulator cleared by the U.S. Food and Drug Administration to be used while sleeping. In addition to its pain relief benefits, should SENSUS become dislodged from the skin for any reason, it immediately shuts off.

For more information, visit www.SENSUSRx.com, who paid for the writing and dissemination of this release.

Contact:  Laura Radocaj, Dian Griesel Int'l.
212.825.3210

 


'/>"/>
SOURCE NeuroMetrix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. World Pain Relieving Drug Market 2013-2023
2. Lipitor Lawsuit News: As Lipitor Diabetes Lawsuits Move Forward, Bernstein Liebhard LLP Comments on JAMA Editorial Expressing Concern about the "Statinization" of U.S.
3. Synthetic Biologics Enters into License with Cedars-Sinai Medical Center to Develop Novel Anti-infective Approaches for Irritable Bowel Syndrome (IBS), Obesity and Diabetes
4. Largest Global Survey Investigating Early Type 2 Diabetes Conversations Launched by Boehringer Ingelheim and Eli Lilly and Company in Partnership with the International Diabetes Federation
5. Surveyed Endocrinologists Consider Eli Lillys Dulaglutide To Have an Edge Over Competitors for the Treatment of Type 2 Diabetes Patients Who Are Inadequately Controlled On Metformin
6. PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022
7. Diabetes, Metabolic Syndrome and Cardiovascular Disease
8. How Some People with Diabetes Can Eliminate the Pain of a Daily Procedure
9. Tandem Diabetes Care Announces Closing of Initial Public Offering
10. Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Initial Public Offering of Common Stock
11. Bone-Breaking News: Mayo Clinic Solves Mysterious Link Between Diabetes and Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... and BOSTON , ... a leading global pharmaceutical company and Paratek Pharmaceuticals, ... the development and commercialization of innovative therapies based ... 3 trials of sarecycline for the treatment of ... primary efficacy endpoints. Sarecycline is a once-daily, oral, ...
(Date:3/27/2017)... 2017  PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical ... diseases in children, today reported financial results for ... 31, 2016 and provided an update on its ... make progress during the fourth quarter of 2016 ... primate safety study, and with our lead development ...
(Date:3/24/2017)... Research and Markets has announced the ... report to their offering. ... The Cell Therapy Manufacturing Market, 2017-2027 report ... cell therapy manufacturing and focuses both on contract manufacturers and ... anticipated to emerge as viable alternatives to conventional treatment options. ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... March 27, 2017 , ... ... it will co-exhibit with technology partners LG Business Solutions at ATARC Federal ... Center in Washington D.C., will provide education and examination into the mobility tools ...
(Date:3/27/2017)... ... March 27, 2017 , ... American Veterinarian™, ... coverage on veterinary medicine, announces the launch of Veterinarian’s Money Digest™, a business ... the April edition of American Veterinarian™. , “We look forward to ...
(Date:3/27/2017)... ... March 27, 2017 , ... Kwalu, a leading provider ... a row; they are the recipient of the prestigious “Best Overall Design Strategy ... award at Design Connections 2017. Top A&D professionals from leading firms, furniture manufacturers ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... testing methods are complicated and require expert user knowledge. In a live webinar ... dedicated to the simplified, yet highly accurate, determination of sodium. , It has ...
(Date:3/27/2017)... Fla. (PRWEB) , ... March 27, 2017 , ... The ... and the number of homeowners utilizing DIY and unlicensed contractors for renovations is also ... remodel or replacement project in 2015, and of those, 42% failed to use a ...
Breaking Medicine News(10 mins):